A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults

被引:51
作者
Llabre, Maria M.
Weaver, Kathryn E.
Duran, Ron E.
Antoni, Michael H.
McPherson-Baker, Shvawn
Schneiderman, Neil
机构
[1] Univ Miami, Dept Psychol, Coral Gables, FL USA
[2] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
[3] Calif Sch Profess Psychol, San Diego, CA 92121 USA
[4] Miami Univ, Dept Microbiol & Immunol, Miami, FL USA
关键词
D O I
10.1089/apc.2006.20.701
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This study compared a multiple method measurement model of highly active antiretroviral therapy (HAART) adherence with single- method models to determine optimal validity in predicting HIV viral load. Repeated measures of antiretroviral adherence were collected over a 15-month period using three different measurement methods: a self-report questionnaire, an adherence interview item, and electronic medication monitoring. The participants included HIV-positive men and women (n = 323) who were currently prescribed HAART. Single-factor models composed of multiple measurements over time were developed for each adherence method and HIV viral load. The three adherence methods were then combined in a second order factor measurement model. Structural equation modeling was used to test the models. Mean adherence, defined as percent of doses taken, was 92%, 90%, and 57% by self-report, interview, and electronic monitoring, respectively. Reliability of individual measurements of adherence was low. Four or seven assessments were needed to attain acceptable stability, depending on the method. The second-order factor model of adherence fit the data and explained 45% of the variability in HIV viral load. Models including only one method of assessing adherence explained between 20% and 24% of the variability. Models that included both self-report and electronic monitoring optimized predictive validity. Using at least two different methods of adherence measurement, each assessed at multiple times is recommended to derive reliable and valid measurement of medication adherence, which is predictive of biological outcomes such as HIV viral load.
引用
收藏
页码:701 / 711
页数:11
相关论文
共 36 条
[1]  
Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006
[2]  
[Anonymous], 2001, AIDS and Behavior
[3]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[4]  
Bangsberg D.R., 2001, AIDS Behav, V5, P275, DOI [10.1023/A:1011396711486, DOI 10.1023/A:1011396711486]
[5]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[6]   Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations [J].
Bova, CA ;
Fennie, KP ;
Knafl, GJ ;
Dieckhaus, KD ;
Watrous, E ;
Williams, AB .
AIDS AND BEHAVIOR, 2005, 9 (01) :103-110
[7]   Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease [J].
Catz, SL ;
Kelly, JA ;
Bogart, LM ;
Benotsch, EG ;
McAuliffe, TL .
HEALTH PSYCHOLOGY, 2000, 19 (02) :124-133
[8]  
*CDCP, 2001, HIV AIDS SURV REP AT
[9]   Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments [J].
Chesney, MA ;
Ickovics, JR ;
Chambers, DB ;
Gifford, AL ;
Neidig, J ;
Zwickl, B ;
Wu, AW .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03) :255-266
[10]   Adherence to HIV combination therapy [J].
Chesney, MA ;
Morin, M ;
Sherr, L .
SOCIAL SCIENCE & MEDICINE, 2000, 50 (11) :1599-1605